Logo image of TSAT

TELESAT CORP (TSAT) Stock Fundamental Analysis

NASDAQ:TSAT - Nasdaq - CA8795123097 - Common Stock - Currency: USD

15.67  -0.03 (-0.19%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to TSAT. TSAT was compared to 33 industry peers in the Diversified Telecommunication Services industry. TSAT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TSAT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

TSAT had negative earnings in the past year.
In the past year TSAT had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: TSAT reported negative net income in multiple years.
In the past 5 years TSAT always reported a positive cash flow from operatings.
TSAT Yearly Net Income VS EBIT VS OCF VS FCFTSAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

TSAT has a Return On Assets of -1.24%. This is in the lower half of the industry: TSAT underperforms 60.61% of its industry peers.
Looking at the Return On Equity, with a value of -12.49%, TSAT is doing worse than 69.70% of the companies in the same industry.
TSAT has a Return On Invested Capital (2.33%) which is in line with its industry peers.
TSAT had an Average Return On Invested Capital over the past 3 years of 3.76%. This is below the industry average of 7.29%.
Industry RankSector Rank
ROA -1.24%
ROE -12.49%
ROIC 2.33%
ROA(3y)0.29%
ROA(5y)1.38%
ROE(3y)2.17%
ROE(5y)9.65%
ROIC(3y)3.76%
ROIC(5y)4.41%
TSAT Yearly ROA, ROE, ROICTSAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100

1.3 Margins

TSAT has a better Operating Margin (34.67%) than 96.97% of its industry peers.
In the last couple of years the Operating Margin of TSAT has declined.
With an excellent Gross Margin value of 93.65%, TSAT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
TSAT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 34.67%
PM (TTM) N/A
GM 93.65%
OM growth 3Y-0.65%
OM growth 5Y-5.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.93%
GM growth 5Y-0.54%
TSAT Yearly Profit, Operating, Gross MarginsTSAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TSAT is destroying value.
The number of shares outstanding for TSAT has been increased compared to 1 year ago.
The number of shares outstanding for TSAT has been reduced compared to 5 years ago.
The debt/assets ratio for TSAT has been reduced compared to a year ago.
TSAT Yearly Shares OutstandingTSAT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
TSAT Yearly Total Debt VS Total AssetsTSAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

TSAT has an Altman-Z score of 0.55. This is a bad value and indicates that TSAT is not financially healthy and even has some risk of bankruptcy.
TSAT has a Altman-Z score of 0.55. This is in the lower half of the industry: TSAT underperforms 69.70% of its industry peers.
TSAT has a Debt/Equity ratio of 4.73. This is a high value indicating a heavy dependency on external financing.
TSAT's Debt to Equity ratio of 4.73 is on the low side compared to the rest of the industry. TSAT is outperformed by 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.73
Debt/FCF N/A
Altman-Z 0.55
ROIC/WACC0.41
WACC5.66%
TSAT Yearly LT Debt VS Equity VS FCFTSAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

2.3 Liquidity

TSAT has a Current Ratio of 5.63. This indicates that TSAT is financially healthy and has no problem in meeting its short term obligations.
TSAT's Current ratio of 5.63 is amongst the best of the industry. TSAT outperforms 96.97% of its industry peers.
A Quick Ratio of 5.63 indicates that TSAT has no problem at all paying its short term obligations.
TSAT has a Quick ratio of 5.63. This is amongst the best in the industry. TSAT outperforms 96.97% of its industry peers.
Industry RankSector Rank
Current Ratio 5.63
Quick Ratio 5.63
TSAT Yearly Current Assets VS Current LiabilitesTSAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2

3. Growth

3.1 Past

TSAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -176.60%.
Looking at the last year, TSAT shows a very negative growth in Revenue. The Revenue has decreased by -20.41% in the last year.
The Revenue has been decreasing by -8.92% on average over the past years.
EPS 1Y (TTM)-176.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%214.85%
Revenue 1Y (TTM)-20.41%
Revenue growth 3Y-9.02%
Revenue growth 5Y-8.92%
Sales Q2Q%-23.28%

3.2 Future

The Earnings Per Share is expected to decrease by -25.06% on average over the next years. This is quite bad
The Revenue is expected to grow by 15.49% on average over the next years. This is quite good.
EPS Next Y-33.39%
EPS Next 2Y-49.13%
EPS Next 3Y-25.06%
EPS Next 5YN/A
Revenue Next Year-25.98%
Revenue Next 2Y-19.72%
Revenue Next 3Y-6.77%
Revenue Next 5Y15.49%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TSAT Yearly Revenue VS EstimatesTSAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
TSAT Yearly EPS VS EstimatesTSAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TSAT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TSAT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TSAT Price Earnings VS Forward Price EarningsTSAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as TSAT.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.35
TSAT Per share dataTSAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20 -30

4.3 Compensation for Growth

A cheap valuation may be justified as TSAT's earnings are expected to decrease with -25.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-49.13%
EPS Next 3Y-25.06%

0

5. Dividend

5.1 Amount

TSAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TELESAT CORP

NASDAQ:TSAT (5/23/2025, 9:00:11 PM)

15.67

-0.03 (-0.19%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)N/A N/A
Inst Owners54.72%
Inst Owner Change-0.03%
Ins Owners12.4%
Ins Owner Change0%
Market Cap791.34M
Analysts80
Price Target32.13 (105.04%)
Short Float %1.73%
Short Ratio2.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)37.73%
Min EPS beat(2)-110.16%
Max EPS beat(2)185.61%
EPS beat(4)3
Avg EPS beat(4)129.7%
Min EPS beat(4)-110.16%
Max EPS beat(4)377.21%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.59%
Min Revenue beat(2)3.16%
Max Revenue beat(2)4.03%
Revenue beat(4)3
Avg Revenue beat(4)3.23%
Min Revenue beat(4)-0.09%
Max Revenue beat(4)5.84%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)53.66%
EPS NQ rev (1m)-80.83%
EPS NQ rev (3m)50.68%
EPS NY rev (1m)-76.08%
EPS NY rev (3m)41.71%
Revenue NQ rev (1m)3.77%
Revenue NQ rev (3m)-9.16%
Revenue NY rev (1m)0.47%
Revenue NY rev (3m)-6.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.05
P/FCF N/A
P/OCF 8.72
P/B 1.55
P/tB N/A
EV/EBITDA 11.35
EPS(TTM)-2.26
EYN/A
EPS(NY)-8.76
Fwd EYN/A
FCF(TTM)-17.13
FCFYN/A
OCF(TTM)1.8
OCFY11.47%
SpS7.65
BVpS10.12
TBVpS-34.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.24%
ROE -12.49%
ROCE 2.68%
ROIC 2.33%
ROICexc 2.63%
ROICexgc 5.33%
OM 34.67%
PM (TTM) N/A
GM 93.65%
FCFM N/A
ROA(3y)0.29%
ROA(5y)1.38%
ROE(3y)2.17%
ROE(5y)9.65%
ROIC(3y)3.76%
ROIC(5y)4.41%
ROICexc(3y)4.87%
ROICexc(5y)5.57%
ROICexgc(3y)14.76%
ROICexgc(5y)17.44%
ROCE(3y)4.34%
ROCE(5y)5.08%
ROICexcg growth 3Y-28.13%
ROICexcg growth 5Y-25.47%
ROICexc growth 3Y-17.12%
ROICexc growth 5Y-18.41%
OM growth 3Y-0.65%
OM growth 5Y-5.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.93%
GM growth 5Y-0.54%
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 4.73
Debt/FCF N/A
Debt/EBITDA 10.42
Cap/Depr 973.23%
Cap/Sales 247.48%
Interest Coverage 1.06
Cash Conversion 39.08%
Profit Quality N/A
Current Ratio 5.63
Quick Ratio 5.63
Altman-Z 0.55
F-Score3
WACC5.66%
ROIC/WACC0.41
Cap/Depr(3y)301.38%
Cap/Depr(5y)217.49%
Cap/Sales(3y)74.26%
Cap/Sales(5y)55.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-176.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%214.85%
EPS Next Y-33.39%
EPS Next 2Y-49.13%
EPS Next 3Y-25.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-20.41%
Revenue growth 3Y-9.02%
Revenue growth 5Y-8.92%
Sales Q2Q%-23.28%
Revenue Next Year-25.98%
Revenue Next 2Y-19.72%
Revenue Next 3Y-6.77%
Revenue Next 5Y15.49%
EBIT growth 1Y-70.71%
EBIT growth 3Y-9.61%
EBIT growth 5Y-14.06%
EBIT Next Year-12.59%
EBIT Next 3Y-11.74%
EBIT Next 5Y26.1%
FCF growth 1Y-779.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-49.27%
OCF growth 3Y-40.49%
OCF growth 5Y-30.15%